Lornoxicam Versus Etodolac After Third Molar Surgery
Comparison of Lornoxicam and Etodolac on Edema, Trismus and Pain After Third Molar Surgery
1 other identifier
interventional
20
1 country
1
Brief Summary
Our study aimed to compare the effect of lornoxicam and etodolac on postoperative pain, edema and trismus following lower third molar extraction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Jul 2022
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2022
CompletedFirst Submitted
Initial submission to the registry
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
January 11, 2023
CompletedJanuary 11, 2023
December 1, 2022
2 months
October 31, 2022
December 23, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Pain after wisdom tooth extraction
Pain after lower third molar removal, Pain was evaluated with VAS(visual anolog scale)
2 th hours
Edema after wisdom tooth extraction
Edema lower third molar removal, Edema was evaluated by using reference line on the face
48 th hours
Trismus after wisdom tooth extraction
Trismus lower third molar removal, trismus was evaluated by using caliper
48 th hours,
Secondary Outcomes (6)
Pain after wisdom tooth extraction
6 th hours
Pain after wisdom tooth extraction
12 th hours
Pain after wisdom tooth extraction
24 th hours
Pain after wisdom tooth extraction
48 th hours
Edema after wisdom tooth extraction
168 th hours
- +1 more secondary outcomes
Study Arms (2)
Etodolac
ACTIVE COMPARATOREtodolac, 400 mg tid per a day for four days
Lornoxicam
ACTIVE COMPARATORLornoxicam, 8 mg twice per day for four days
Interventions
Lornoxicam is a oxicam grup non-steroid antiinflamatuar drug
Eligibility Criteria
You may qualify if:
- Bilateral mesioangular impacted lower third molar
- Asymptomatic Third Molar (No history of infection)
- Systemically Healthy Person
- Person Between aged 18-30
You may not qualify if:
- People who are pregnant and lactation process
- People who had any systemic disease
- People who are gastrointestinal problems
- People who are sensitive to drugs used in study
- Lower Third Molar associated with cysts and infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zülfikar Karabıyık
Kütahya, 43000, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
October 31, 2022
First Posted
January 11, 2023
Study Start
July 20, 2022
Primary Completion
September 25, 2022
Study Completion
September 29, 2022
Last Updated
January 11, 2023
Record last verified: 2022-12